LTC1781277I2 - - Google Patents

Info

Publication number
LTC1781277I2
LTC1781277I2 LTPA2024501C LTPA2024501C LTC1781277I2 LT C1781277 I2 LTC1781277 I2 LT C1781277I2 LT PA2024501 C LTPA2024501 C LT PA2024501C LT PA2024501 C LTPA2024501 C LT PA2024501C LT C1781277 I2 LTC1781277 I2 LT C1781277I2
Authority
LT
Lithuania
Application number
LTPA2024501C
Original Assignee
Aft Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Limited filed Critical Aft Pharmaceuticals Limited
Publication of LTPA2024501I1 publication Critical patent/LTPA2024501I1/lt
Publication of LTC1781277I2 publication Critical patent/LTC1781277I2/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
LTPA2024501C 2004-07-07 2024-01-23 LTC1781277I2 (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ53398204 2004-07-07
PCT/NZ2005/000168 WO2006004449A2 (en) 2004-07-07 2005-07-07 A combination composition

Publications (2)

Publication Number Publication Date
LTPA2024501I1 LTPA2024501I1 (lt) 2024-02-12
LTC1781277I2 true LTC1781277I2 (lt) 2024-07-10

Family

ID=35783254

Family Applications (1)

Application Number Title Priority Date Filing Date
LTPA2024501C LTC1781277I2 (lt) 2004-07-07 2024-01-23

Country Status (21)

Country Link
US (4) US20080275125A1 (lt)
EP (1) EP1781277B1 (lt)
JP (1) JP5630943B2 (lt)
KR (1) KR101370712B1 (lt)
CN (1) CN101022789A (lt)
AT (1) ATE543491T1 (lt)
AU (2) AU2005260243B2 (lt)
BR (1) BRPI0512756A (lt)
CA (1) CA2570474C (lt)
CY (2) CY1112738T1 (lt)
DK (1) DK1781277T3 (lt)
ES (1) ES2381794T3 (lt)
GB (1) GB2431346C (lt)
LT (1) LTC1781277I2 (lt)
MX (1) MX2007000117A (lt)
PL (1) PL1781277T3 (lt)
PT (1) PT1781277E (lt)
RU (2) RU2007101686A (lt)
SI (1) SI1781277T1 (lt)
WO (1) WO2006004449A2 (lt)
ZA (1) ZA200700896B (lt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE543491T1 (de) 2004-07-07 2012-02-15 Aft Pharmaceuticals Ltd Kombinationspräparat enthaltend ibuprofen und paracetamol
WO2007069033A2 (en) * 2005-12-12 2007-06-21 Adcock Ingram Limited Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
CA2666582C (en) * 2006-10-20 2014-09-09 Mcneil-Ppc, Inc. Acetaminophen / ibuprofen combinations
JP5676834B2 (ja) * 2006-11-29 2015-02-25 エスエス製薬株式会社 消化管への刺激性を減少した経口固形組成物
CA2731801C (en) * 2007-07-23 2013-11-26 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
JP2011508768A (ja) * 2008-01-03 2011-03-17 ウォックハート リサーチ センター パラセタモール及びイブプロフェンを含む医薬用経口懸濁剤
US20110166234A1 (en) * 2008-10-14 2011-07-07 Atkinson Hartley Campbell Medicinal product and treatment
DE102010008876B4 (de) 2010-02-22 2017-07-27 Integrated Micro-Electronics Bulgaria Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür
SG186388A1 (en) * 2010-07-07 2013-01-30 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
US20130225685A1 (en) * 2010-11-04 2013-08-29 Aft Pharmaceuticals Limited Combination composition
EP2704697B1 (en) * 2011-05-06 2018-09-12 GlaxoSmithKline Consumer Healthcare (UK) IP Limited Sustained release paracetamol formulations
JP6009928B2 (ja) * 2012-12-14 2016-10-19 ダイハツ工業株式会社 車両のサスペンション
KR102373089B1 (ko) * 2017-03-30 2022-03-11 한미약품 주식회사 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법
CN114681324B (zh) * 2017-07-10 2024-05-03 盖尔凯普科技有限公司 双释放剂型胶囊及其制备方法、装置和系统
WO2019108147A1 (en) 2017-11-29 2019-06-06 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Color stable fixed dose tablet combination of ibuprofen and paracetamol
US11197830B2 (en) * 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
PH12021553169A1 (en) * 2019-06-27 2022-08-15 Glaxosmithkline Consumer Healthcare Holdings Us Llc Novel ibuprofen and acetaminophen composition
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605538B2 (en) * 1988-01-19 1991-01-17 Adcock Ingram Limited Pharmaceutical unit
CA1336687C (en) * 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
ZA959469B (en) 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
KR970000231A (ko) * 1995-06-12 1997-01-21 박형미 진통소염제의 의약조성물
JP3982889B2 (ja) 1997-11-28 2007-09-26 あすか製薬株式会社 イブプロフェン含有医薬製剤
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
ATE543491T1 (de) 2004-07-07 2012-02-15 Aft Pharmaceuticals Ltd Kombinationspräparat enthaltend ibuprofen und paracetamol
GB0519350D0 (en) 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
US20090264530A1 (en) 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
US20110166234A1 (en) 2008-10-14 2011-07-07 Atkinson Hartley Campbell Medicinal product and treatment

Also Published As

Publication number Publication date
GB2431346C (en) 2010-02-17
US10532036B2 (en) 2020-01-14
WO2006004449A3 (en) 2006-03-02
GB0700027D0 (en) 2007-02-07
SI1781277T1 (sl) 2012-07-31
CA2570474C (en) 2010-01-05
PT1781277E (pt) 2012-05-07
KR20070034614A (ko) 2007-03-28
DK1781277T3 (da) 2012-05-07
CA2570474A1 (en) 2006-01-12
RU2010147287A (ru) 2012-05-27
GB2431346B (en) 2010-01-27
US20080200549A1 (en) 2008-08-21
BRPI0512756A (pt) 2008-04-08
CN101022789A (zh) 2007-08-22
EP1781277B1 (en) 2012-02-01
ZA200700896B (en) 2008-07-30
JP2008505889A (ja) 2008-02-28
CY1112738T1 (el) 2016-02-10
AU2008202029A1 (en) 2009-11-26
MX2007000117A (es) 2007-06-15
CY2023026I2 (el) 2025-03-28
US20140073696A1 (en) 2014-03-13
RU2455983C1 (ru) 2012-07-20
ATE543491T1 (de) 2012-02-15
JP5630943B2 (ja) 2014-11-26
RU2007101686A (ru) 2008-08-20
AU2005260243A1 (en) 2006-01-12
KR101370712B1 (ko) 2014-03-06
LTPA2024501I1 (lt) 2024-02-12
US20110275718A1 (en) 2011-11-10
GB2431346A (en) 2007-04-25
PL1781277T3 (pl) 2012-07-31
AU2005260243B2 (en) 2009-10-29
EP1781277A4 (en) 2008-09-03
CY2023026I1 (el) 2024-02-16
ES2381794T3 (es) 2012-05-31
EP1781277A2 (en) 2007-05-09
US20080275125A1 (en) 2008-11-06
WO2006004449A2 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
BE2024C508I2 (lt)
BE2023C542I2 (lt)
BE2022C549I2 (lt)
BE2021C001I2 (lt)
BE2020C513I2 (lt)
LTPA2024501I1 (lt)
BE2019C540I2 (lt)
BE2019C523I2 (lt)
BE2019C548I2 (lt)
BE2020C525I2 (lt)
BE2017C027I2 (lt)
BE2017C023I2 (lt)
BE2017C002I2 (lt)
BE2016C067I2 (lt)
BE2016C014I2 (lt)
BE2015C063I2 (lt)
BE2015C041I2 (lt)
BE2015C038I2 (lt)
BE2014C071I2 (lt)
BE2014C064I2 (lt)
BE2015C066I2 (lt)
IN2007MU00366A (lt)
BE2015C065I2 (lt)
BE2019C535I2 (lt)
FR15C0041I1 (lt)